Pandemic logistics: guaranteeing equitable access
The Covid-19 pandemic is a truly global health emergency, and one that will not end...
Read More...
Focus:
-
![Numab Boehringer antibody]()
Numab and Boehringer Ingelheim partner on multi-specific antibody therapies
Numab and Boehringer Ingelheim have teamed up to discover multi-specific antibody-based drugs for lung and...
Read More...
-
![Covid-19 NCSC]()
Covid-19 pandemic: Russian hackers target UK, US and Canadian research
Security services in the UK, US and Canada have determined that the Russian cyber hacking...
Read More...
-
![]()
How biotechs can tap APAC for excellence in oncology trials
Asia-Pacific biotech specialist CRO Novotech has released a new webinar about the advantages of conducting oncology clinical trials in the…
Read More…
-
![Revitope Junshi]()
Revitope and Junshi collaborate on improved T-cell engager antibodies
Revitope and Junshi have teamed up to create next-generation T-cell engager cancer therapies; for the...
Read More...
-
![]()
From rare diseases to Covid-19: charting the history of Genomics England
Genomic England is participating in a £28m nationwide human genome sequencing project to try and...
Read More...
-
![Kiadis Sanofi NK cell therapy]()
Sanofi licenses Kiadis’s modified NK cell therapy for multiple myeloma
Sanofi has licensed Kiadis’s modified K-NK cell therapies to combine with its anti-CD38 antibody Sarclissa...
Read More...
-
![Pharmacy fridges]()
New pharma fridges provide visibility, productivity and prevent loss
The pharmaceutical industry is seeing a significant shift toward automation. Because of this, more is expected from the industry than…
Read More…
-
![MSF COVAX]()
Access to Covid-19 vaccines: MSF’s concerns about Gavi’s COVAX AMC
Gavi’s COVAX Facility and associated AMC aims to facilitate fair access to Covid-19 vaccines. However,...
Read More...
-
![COVAX AMC]()
Access to Covid-19 vaccines: deep dive into Gavi’s COVAX AMC
The only way the Covid-19 pandemic can be brought to an end is if everyone...
Read More...
